CIK 0001730430 · Large accelerated filer
Kiniksa Pharmaceuticals International, plc
Sign in to watch- Ticker
- KNSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981795578
- Phone
- 7814319100
- Business address
- 105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
- Former names
- Kiniksa Pharmaceuticals, Ltd.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $78,588,440
- in 8 filings, $78.6M under 10b5-1 plans
Net −$78,588,440. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Patel Sanj K −$51.7M CHAIRMAN & CEO sold 42% of stake
- Moat Ross −$9.6M CHIEF OPERATING OFFICER sold 91% of stake
- Paolini John F. −$8.9M CHIEF MEDICAL OFFICER sold 58% of stake
- Megna Michael R −$4.9M CHIEF ACCOUNTING OFFICER sold 80% of stake
- Ragosa Mark −$3.4M CHIEF FINANCIAL OFFICER sold 64% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-06-10 | Beetham Thomas W. EVP & Chief Legal Officer | Sale | −13,752 | $25.07 | $345K | 29,589 |
| 2020-06-10 | Beetham Thomas W. EVP & Chief Legal Officer | Option exercise · Share Option | −13,752 | 112,189 | ||
| 2020-05-18 | BAKER BROS. ADVISORS LP Director | Grant or award · Class A1 Common Shares | +134,397 | $18.25 | $2.5M | 1,050,440 |
| 2020-05-18 | BAKER BROS. ADVISORS LP Director | Grant or award · Class A1 Common Shares | +1,465,603 | $18.25 | $26.7M | 10,302,952 |
| 2020-04-21 | Beetham Thomas W. EVP & Chief Legal Officer | Sale | −1,563 | $19.56 | $31K | 30,544 |
| 2020-04-21 | Beetham Thomas W. EVP & Chief Legal Officer | Sale | −955 | $20.44 | $20K | 29,589 |
| 2020-04-20 | Beetham Thomas W. EVP & Chief Legal Officer | Sale | −47,423 | $19.06 | $904K | 32,107 |
| 2020-03-13 | Patel Sanj K Chairman & CEO | Grant or award · Share Option | +180,000 | 180,000 | ||
| 2020-03-13 | Beetham Thomas W. EVP & Chief Legal Officer | Grant or award · Share Option | +75,000 | 75,000 | ||
| 2020-03-13 | Rizvi Qasim Chief Commercial Officer | Grant or award · Share Option | +75,000 | 75,000 | ||
| 2020-03-13 | Paolini John F. SVP & Chief Medical Officer | Grant or award · Share Option | +50,000 | 50,000 | ||
| 2020-03-13 | Megna Michael R Chief Accounting Officer | Grant or award · Share Option | +17,000 | 17,000 | ||
| 2020-03-06 | Patel Sanj K Chairman & CEO | Sale | −33,115 | $20.00 | $662K | 212,570 |
| 2020-02-27 | Paolini John F. SVP & Chief Medical Officer | Option exercise | +12,000 | $1.86 | $22K | 30,000 |
| 2020-02-27 | Paolini John F. SVP & Chief Medical Officer | Option exercise · Share Option | −12,000 | 197,574 | ||
| 2020-02-20 | Paolini John F. SVP & Chief Medical Officer | Option exercise | +9,803 | $3.80 | $37K | 27,803 |
| 2020-02-20 | Paolini John F. SVP & Chief Medical Officer | Sale | −8,687 | $18.91 | $164K | 19,116 |
| 2020-02-20 | Paolini John F. SVP & Chief Medical Officer | Sale | −1,116 | $19.32 | $22K | 18,000 |
| 2020-02-20 | Paolini John F. SVP & Chief Medical Officer | Option exercise · Share Option | −9,803 | 66,542 | ||
| 2020-02-19 | Paolini John F. SVP & Chief Medical Officer | Option exercise | +22,477 | $3.80 | $85K | 40,477 |
Page 75 of 80 · 1,595 trades